SQZ Biotechnologies

NYSE: SQZ · Real-Time Price · USD
0.43
0.16 (59.26%)
At close: Jul 03, 2023, 7:00 PM

SQZ Biotechnologies Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-79.46M -68.74M
Depreciation & Amortization
11.68M 11.03M
Stock-Based Compensation
8.4M 8.51M
Other Working Capital
-25.78M -24.2M
Other Non-Cash Items
33K 7K
Deferred Income Tax
n/a n/a
Change in Working Capital
-24.2M -32.94M
Operating Cash Flow
-83.55M -82.14M
Capital Expenditures
-522K -613K
Cash Acquisitions
n/a n/a
Purchase of Investments
n/a n/a
Sales Maturities Of Investments
n/a n/a
Other Investing Acitivies
34K n/a
Investing Cash Flow
-488K -613K
Debt Repayment
n/a n/a
Common Stock Repurchased
29K 103K
Dividend Paid
n/a n/a
Other Financial Acitivies
4.23M 55.91M
Financial Cash Flow
4.23M 55.91M
Net Cash Flow
-79.8M -26.84M
Free Cash Flow
-84.07M -82.75M